close

Register today to unlock Valuecruncher and get unlimited access

  • Get unlimited access to all compartors and data
  • Save and share valuations as well as comment on others
  • Alter and save your favourite comparator companies

Already registered? Please login now

Comparison Analysis  

What's this?
Dollar2Point57
Implied share price

Buy Undervalued by 12750.0%

5% margin of safety What's this?

EV / Revenue
Use Average
OSCI
Oscient Pharmaceuticals Corporation
GILD
Gilead Sciences, Inc.
Change
AMGN
Amgen, Inc.
Change
SNY
Sanofi SA (ADR)
Change
NVO
Novo Nordisk A/S (ADR)
Change
3.29 2.13 4.26 5.6 1.84 1.1
All amounts in millions
from last financial year
         
Implied Share Price $2.57 $73.66 $94.51 $82.48 $149.91
Market Cap 0 131,400 120,755 113,905 110,315
Net Debt 184 7,571 174 7,295 -19,392
Enterprise Value (EV) 185 138,971 121,260 64,076 118,516
Revenue 86 32,639 21,662 34,861 107,927
Balance Sheet          
Total Assets 174 51,839 71,576 102,321 91,799
Total Liabilities 255 33,305 43,493 44,272 44,830
Shareholders Equity -81 18,534 28,083 58,049 46,969.0

Where are the EBIT and EBITDA figures?

Certain companies and those in specific industries (for example insurance) do not report financial results at the EBIT or EBITDA line. For these companies where Valuecruncher does not have EBIT or EBITDA numbers we exclude the valuation metrics driven by these figures. Valuecruncher makes our other valuation metrics available for these companies.

To learn more about comparison analysis, please read our guide to comparison analysis

Comments

No comments yet. Login to comment.